Multidisciplinary Approach to the Diagnosis of Occult Primary Neuroendocrine Neoplasm : A Clinical Challenge
Approximately 11% to 14% of subjects with neuroendocrine neoplasms (NENs) have metastatic lesions with unknown primary origin (UPO), with the majority of UPO-NENs found in the small bowel. Herein, we assessed the available literature on UPO-NENs, focusing on clinical presentation and diagnostic techniques to identify the primary site. The identification of the primary tumor is important as it affects the prognosis; however, the clinical presentation can be non-specific in non-functioning forms. In the presence of metastatic disease, the histological sample is fundamental to obtain immunohistochemical markers that might orientate the clinician in the search for the primary tumor through radiology, functional imaging and endoscopic techniques. In summary, multidisciplinary management plays a key role in UPO-NENs, even more than in other NENs. Molecular biology and gene-expression profiling represent areas of great interest which might be developed in the near future for both the diagnosis and the treatment of these neoplasms.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:12 |
|---|---|
| Enthalten in: |
Journal of clinical medicine - 12(2023), 17 vom: 25. Aug. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Rossi, Roberta Elisa [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Capsule endoscopy |
|---|
| Anmerkungen: |
Date Revised 11.09.2023 published: Electronic Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.3390/jcm12175537 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM361830963 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM361830963 | ||
| 003 | DE-627 | ||
| 005 | 20231226085956.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3390/jcm12175537 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1206.xml |
| 035 | |a (DE-627)NLM361830963 | ||
| 035 | |a (NLM)37685605 | ||
| 035 | |a (PII)5537 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Rossi, Roberta Elisa |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Multidisciplinary Approach to the Diagnosis of Occult Primary Neuroendocrine Neoplasm |b A Clinical Challenge |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 11.09.2023 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a Approximately 11% to 14% of subjects with neuroendocrine neoplasms (NENs) have metastatic lesions with unknown primary origin (UPO), with the majority of UPO-NENs found in the small bowel. Herein, we assessed the available literature on UPO-NENs, focusing on clinical presentation and diagnostic techniques to identify the primary site. The identification of the primary tumor is important as it affects the prognosis; however, the clinical presentation can be non-specific in non-functioning forms. In the presence of metastatic disease, the histological sample is fundamental to obtain immunohistochemical markers that might orientate the clinician in the search for the primary tumor through radiology, functional imaging and endoscopic techniques. In summary, multidisciplinary management plays a key role in UPO-NENs, even more than in other NENs. Molecular biology and gene-expression profiling represent areas of great interest which might be developed in the near future for both the diagnosis and the treatment of these neoplasms | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a capsule endoscopy | |
| 650 | 4 | |a diagnosis | |
| 650 | 4 | |a double-balloon enteroscopy | |
| 650 | 4 | |a immunohistochemistry | |
| 650 | 4 | |a molecular biology | |
| 650 | 4 | |a neuroendocrine neoplasms | |
| 650 | 4 | |a treatment | |
| 650 | 4 | |a ultrasound endoscopy | |
| 650 | 4 | |a unknown primary tumor | |
| 700 | 1 | |a Corti, Francesca |e verfasserin |4 aut | |
| 700 | 1 | |a Pusceddu, Sara |e verfasserin |4 aut | |
| 700 | 1 | |a Milione, Massimo |e verfasserin |4 aut | |
| 700 | 1 | |a Coppa, Jorgelina |e verfasserin |4 aut | |
| 700 | 1 | |a Masoni, Benedetta |e verfasserin |4 aut | |
| 700 | 1 | |a Oldani, Simone |e verfasserin |4 aut | |
| 700 | 1 | |a Sabella, Giovanna |e verfasserin |4 aut | |
| 700 | 1 | |a Cafaro, Pietro |e verfasserin |4 aut | |
| 700 | 1 | |a Repici, Alessandro |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of clinical medicine |d 2012 |g 12(2023), 17 vom: 25. Aug. |w (DE-627)NLM230666310 |x 2077-0383 |7 nnns |
| 773 | 1 | 8 | |g volume:12 |g year:2023 |g number:17 |g day:25 |g month:08 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3390/jcm12175537 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 12 |j 2023 |e 17 |b 25 |c 08 | ||